In this study, we have demonstrated that HSP90 is overexpressed in CLL cells that controls key signal mediators of the BCR pathway including CD79a, BCAP, PLCγ2, LYN, SYK, BTK and AKT. This evidence concerns the gene AKT1 and B-cell chronic lymphocytic leukemia.